[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"low-vision-aids\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:low-vision-aids":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100524373","beacon-sensors-and-telerehabilitation-to-assess-and-improve-use-of-devices-best-aid-for-low-vision-100524373",false,"NCT06107881","Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision","BeST-AID","Inclusion Criteria:\n\n* adults with any level of vision loss due to any ocular disease who are age 18 and older, and who have received new magnification device(s) for the first time (i.e., hand-held optical magnifiers, portable electronic video magnifiers, high near add powers of +4.00 or greater, visual assistive mobile apps for their smartphone\u002Ftablet, some stand magnifiers and CCTVs) from one of our participating low vision rehabilitation sites at the four academic centers and one private practice.\n\nExclusion Criteria:\n\n* schedules not permitting participation in planned study visits (including planning to move far from their clinical provider's office within the first 4-months of the study (i.e., cannot attend in-office visits) or take extended vacation that would not allow them to complete study procedures during the first four months of the study period),\n* inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (greater than mild cognitive impairment as per TICS),\n* substance abuse,\n* significant hearing loss (unable to hear communication by phone or via videoconferencing),\n* significant medical condition likely to limit participation or lifespan,\n* individuals who require other types of LVR training or intervention (e.g., psychosocial).\n* For Bluetooth low energy beacon sensors, exclusion would occur if their magnifier device has features that would not work in conjunction with the beacon sensors: (1) hands-free and do not have a place where the patient's hand is holding the device during use (therefore, they would not register a significant change in temperature), (2) no surface area of at least 1\"x1\" to which the beacon sensor could be attached without interfering with the device, or (3) use of visual assistive mobile apps only.","ALL","18 Years",{"count":19,"type":20},350,"ESTIMATED","INTERVENTIONAL",[23],"NA","One goal of this research is to conduct a non-inferiority trial of telerehabilitation versus in-office care to provide follow-up training to individuals with low vision to enhance their quality of life by using magnification devices and\u002For visual assistive mobile apps for important daily activities, such as reading and\u002For other valued tasks. This is a high priority given the increasing prevalence of low vision, paucity of low vision rehabilitation providers, and barriers related to access to care, such as transportation and geography, which can be essentially eliminated with telerehabilitation. Another goal of this project is to determine whether significant changes in environmental data collected by Bluetooth low energy beacon sensors can be used as a solution to monitor and indicate when low vision patients' have abandoned the use of their magnification devices, which has the potential to substantially enhance patient management by providing timely low vision rehabilitation services.",[26,27],"Low Vision","Low Vision Aids","RECRUITING","2025-09-18",{"date":31,"type":32},"2025-09-23","ACTUAL",{"date":34,"type":32},"2023-12-15",{"date":36,"type":20},"2028-06-30",{"name":38,"class":39},"University of California, Los Angeles","OTHER",9,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":48,"enrollmentInfo":49,"targetDuration":4,"studyType":21,"phases":51,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":63},"100604418","assessing-the-impact-of-esight-go-at-home-usage-in-individuals-with-visual-impairment-100604418","NCT07149259","Assessing the Impact of eSight Go At-Home Usage in Individuals With Visual Impairment","eSight","Inclusion Criteria:\n\n* Aged 18 to 90.\n* Best-corrected visual acuity between 20\u002F50 to 20\u002F400 in the better eye.\n* Subjects who have been diagnosed with an ocular condition causing visual impairment\n* Have a functional binocular field of view of at least 20 degrees.\n* Visual status stable for at least six months.\n* Demonstrate visual benefit from magnification.\n* Agree to wear the eSight Go in a variety of situations in the home and community.\n* Score ≥ 20 on the Short Orientation-Memory-Concentration Test of Cognitive Impairment (OMCT).\n* Subject must be able to provide an informed consent\n* Subject must agree to use eSight Eyewear only under conditions that will not jeopardize the safety of either the user or the device.\n\nExclusion Criteria:\n\n* Participant must not be currently undergoing any medical or surgical procedures resulting in unstable vision.\n* Participants who have undergone cataract, refractive, or other surgical procedures related to vision in the six-month period prior to study enrollment.\n* Severe (\\>20\u002F400) visual impairment in the better seeing eye.\n* Cognitive limitations (\\\u003C 20 on OMCT).\n* Participants who have undergone any vision-related injections (e.g. anti-VEGF) in the two-month period prior to the study because of active bleeding in the retina. Ongoing anti-VEGF treatments are permitted if the participant is in a \"Treat and Extend\" or pro re nata (\"PRN\") disease management, and macula is dry.\n* Participants are unable or unwilling to adhere to the examination schedules as they are described in the study protocol. This may also include participants already enrolled, who for whatever reason, have become unable or unwilling to continue the study. This may also include participants for whom the travel time to\u002Ffrom the study site is unacceptable.\n* Participants who self-report a history of alcoholism, drug abuse, or psychosis.\n* Participants who exhibit clinical evidence of depression, poor motivation, emotional or intellectual problems, or any other conditions which would likely limit validity of consent or appropriate responses to participate in the study or who are deemed unsuitable psychologically or physiologically for study participation by the investigator.\n* Participants who may have a conflict of interest with eSight Corp, which could reasonably influence their participation in the study.\n* Refractive error outside the range correctable by lens inserts in the device (\\> +\u002F-8.00 D sph or -4.00 cyl)","90 Years",{"count":50,"type":20},50,[23],"This research aims to test the updated version of Gentex's device, eSight Go, an image enhancing wearable device to assist those with vision impairments limiting activities of daily living.",[27],"2025-08-27",{"date":56,"type":32},"2025-08-29",{"date":58,"type":32},"2025-06-18",{"date":60,"type":20},"2026-06-01",{"name":62,"class":39},"Brooks Rehabilitation",1]